Oncolytics Biotech Inc (ONCY)

02:02 AM

(ONC) Long Term Investment Analysis (ONC:CA) - news.stocktradersdaily.com

02:02 AM

Apr 19, 2025

Small-cap cancer therapy innovator raises $20M in flexible funding - MSN

Apr 19, 2025

Apr 18, 2025

Investors Eye Biotech Sector as Cancer Therapy Market Surges (PR Newswire) - Aktiellt

Apr 18, 2025

Apr 18, 2025

Oncology Breakthroughs: How Cancer Research Is Advancing in 2025 (PR Newswire) - Aktiellt

Apr 18, 2025

Apr 17, 2025

Buzz on the Bullboards: Energy, cannabis, and biotech shine on the TSX | 2025-04-17 | Investing News - Stockhouse

Apr 17, 2025

Apr 17, 2025

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights - Quantisnow

Apr 17, 2025

Apr 17, 2025

(ONC) Investment Performance Report (ONC:CA) - news.stocktradersdaily.com

Apr 17, 2025

Apr 15, 2025

Oncolytics Biotech : reg; Doses First Patient in Phase 2 BRACELET-1 Study Evaluating Pelareorep-Based Combination Therapies in Metastatic Breast Cancer - marketscreener.com

Apr 15, 2025

Apr 15, 2025

Oncolytic Virus Therapy Market Size, Share and Strategic - openPR.com

Apr 15, 2025

Apr 15, 2025

With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz - The Malaysian Reserve

Apr 15, 2025

Apr 14, 2025

As Cancer Rates Climb, Wall Street Turns Its Gaze Toward New Frontiers in Cancer Treatments - Baystreet.ca

Apr 14, 2025

Apr 11, 2025

Trend Tracker for (ONC) (ONC:CA) - news.stocktradersdaily.com

Apr 11, 2025

Apr 11, 2025

Oncolytics Biotech® and Pelareorep Discussed During Recent H.C. Wainwright Key Opinion Leader Event on Oncolytic Immunotherapies in Breast and Pancreatic Cancers - Eastern Progress

Apr 11, 2025

Apr 11, 2025

Stocks In Play: Oncolytics Biotech Inc By Baystreet.ca - Investing.com Canada

Apr 11, 2025

Apr 11, 2025

Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Developm - GuruFocus

Apr 11, 2025

Apr 11, 2025

Stocks in play: Oncolytics Biotech Inc - Barchart.com

Apr 11, 2025

Apr 11, 2025

Oncolytics Biotech Inc - Baystreet.ca

Apr 11, 2025

Apr 11, 2025

Small-cap cancer therapy innovator raises $20M in flexible funding | 2025-04-11 | Investing News - Stockhouse

Apr 11, 2025

Apr 11, 2025

Oncolytics secures $20 million to advance cancer therapy development - The Pharma Letter

Apr 11, 2025

Apr 11, 2025

Oncolytics Biotech® and Pelareorep Discussed During Recent H.C. - GuruFocus

Apr 11, 2025

Apr 10, 2025

Oncolytics Biotech Secures $20 Million Funding for Pelareorep Development - TipRanks

Apr 10, 2025

Apr 10, 2025

Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital - Barchart.com

Apr 10, 2025

Apr 10, 2025

Oncolytics Biotech® Inc. - MENAFN.com

Apr 10, 2025

Apr 10, 2025

Private Sector Steps Up in Cancer Research as Federal Support Wavers - Baystreet.ca

Apr 10, 2025

Apr 10, 2025

Stocks In Play: Oncolytics Biotech® Inc. - Barchart.com

Apr 10, 2025

Apr 10, 2025

Stocks In Play: Oncolytics Biotech Inc - Barchart.com

Apr 10, 2025

Apr 10, 2025

Oncolytics Biotech’s Pelareorep Gains Attention at Key Oncology Event - TipRanks

Apr 10, 2025

Apr 10, 2025

Cancer Experts Reveal Promising Outlook for Revolutionary Immunotherapy Treatment - Stock Titan

Apr 10, 2025

Apr 10, 2025

Indo-Asian News Service - Indo-Asian News Service (IANS)

Apr 10, 2025

Apr 08, 2025

(ONC) Optimized Trading Opportunities (ONC:CA) - news.stocktradersdaily.com

Apr 08, 2025

Apr 08, 2025

What Nvidia Stock Investors Should Know About Recent Tariff Updates - The Globe and Mail

Apr 08, 2025

Apr 07, 2025

Mideast stock markets tumble as US tariffs and low oil prices squeeze energy-producing nations - The Globe and Mail

Apr 07, 2025

Apr 02, 2025

Oncolytics Biotech(R) Announces First Patient Treated in Company's AWARE-1 Window of Opportunity Study of Pelareorep in Breast Cancer - ACCESS Newswire

Apr 02, 2025

Apr 02, 2025

Global Cancer Rates Surge as Biotech Innovators Work on New Therapies - Quantisnow

Apr 02, 2025

Mar 31, 2025

Virtu Financial LLC Invests $90,000 in Oncolytics Biotech Inc. (NASDAQ:ONCY) - Defense World

Mar 31, 2025

Mar 16, 2025

Oncolytics Biotech’s Financial Stability at Risk: Urgent Need for New Financing - MSN

Mar 16, 2025

Mar 15, 2025

What is Leede Financial’s Estimate for ONCY FY2025 Earnings? - The AM Reporter

Mar 15, 2025

Mar 14, 2025

FY2027 EPS Estimate for Oncolytics Biotech Lifted by Analyst - Defense World

Mar 14, 2025

Mar 14, 2025

TSE:ONC FY2025 EPS Estimate Lifted by Leede Financial - Defense World

Mar 14, 2025

Mar 13, 2025

HC Wainwright Has Bearish Forecast for ONCY FY2029 Earnings - Defense World

Mar 13, 2025

Mar 13, 2025

HC Wainwright Cuts Earnings Estimates for Oncolytics Biotech - Defense World

Mar 13, 2025

Mar 12, 2025

Oncolytics Biotech® to Participate in a Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference - GuruFocus.com

Mar 12, 2025

Mar 12, 2025

Biotech Advancing Pivotal Phase III Breast Cancer Trial - Streetwise Reports

Mar 12, 2025

Mar 11, 2025

Bridgewater Systems and Oncolytics Biotech Inc. Under Current Evaluation - ACCESS Newswire

Mar 11, 2025

Mar 11, 2025

Oncolytics Biotech (NASDAQ:ONCY) Given Buy Rating at HC Wainwright - Defense World

Mar 11, 2025

Mar 11, 2025

Oncolytics Biotech (NASDAQ:ONCY) Price Target Cut to $3.00 by Analysts at Maxim Group - Defense World

Mar 11, 2025

Mar 11, 2025

Oncolytics Biotech: Continuing To Justify The Negativity - Seeking Alpha

Mar 11, 2025

Mar 10, 2025

Oncolytics Biotech’s Promising Advancements and Strategic Developments Drive Buy Rating - TipRanks

Mar 10, 2025

Mar 10, 2025

Oncolytics price target lowered to $3 from $5 at Maxim - TipRanks

Mar 10, 2025

Mar 08, 2025

Why the Global Cancer Market Could Surpass $900 Billion-And the Stocks Leading the Charge - The Malaysian Reserve

Mar 08, 2025